GQETX
Price
$34.06
Change
+$0.31 (+0.92%)
Updated
Jun 6 closing price
Net Assets
10.7B
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

GQETX vs VITSX

Header iconGQETX vs VITSX Comparison
Open Charts GQETX vs VITSXBanner chart's image
GMO Quality III
Price$34.06
Change+$0.31 (+0.92%)
VolumeN/A
Net Assets10.7B
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
GQETX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GQETX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GQETX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. GQETX (10.7B). VITSX pays higher dividends than GQETX: VITSX (1.29) vs GQETX (0.94). GQETX was incepted earlier than VITSX: GQETX (21 years) vs VITSX (28 years). GQETX (0.51) is less costly to investors than VITSX (0.03). GQETX is a more actively managed with annual turnover of: 19.00 vs. VITSX (2.00). GQETX has a lower initial minimum investment than VITSX: GQETX (1000000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. GQETX (5.25). VITSX return over 5 years is better than : 80.96 vs. GQETX (42.83).
GQETXVITSXGQETX / VITSX
Total Expense Ratio0.500.031,667%
Annual Report Gross Expense Ratio0.510.031,700%
Fund Existence21 years28 years-
Gain YTD3.5280.833423%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets10.7B1.82T1%
Annual Yield % from dividends0.941.2973%
Returns for 1 year5.2510.9748%
Returns for 3 years29.2340.3572%
Returns for 5 years42.8380.9653%
Returns for 10 years72.36180.4940%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.